Nasdaq:US$13.39 (+1.18) | HKEX:HK$19.90 (-0.25) | AIM:£2.09 (-0.1)
News & Presentations
Previous Article   |   Next Article
Announcements & Press Releases, Regulatory Notice | 21 Mar 2018

Director’s Share Dealing

London: Wednesday, March 21, 2018: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has received notification that the spouse of Mr Graeme Jack, Independent Non-executive Director, purchased a total of 3,000 American Depositary Shares of the Company (“ADSs”, each representing one half of one ordinary share of US$1.00 each in the capital of Chi-Med) on March 16, 2018 at a price of US$33.86 per ADS.

Following the above purchase, the spouse of Mr Jack is interested in 3,000 ADSs, representing approximately 0.002% of the current issued share capital of Chi-Med.

Please download the full announcement for the notification as provided in accordance with the requirements of the EU Market Abuse Regulation.